A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

PURPOSE: This study investigated the effect of dual bronchodilation with the long-acting β-receptor agonist/long-acting muscarinic antagonist combination, indacaterol/glycopyrronium (IND/GLY), on nighttime oxygenation, lung function, sleep quality, and symptoms in patients with moderate-to-severe CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Sverre, Ringbæk, Thomas, Løkke, Anders, Grote, Ludger, Hedner, Jan, Lindberg, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330967/
https://www.ncbi.nlm.nih.gov/pubmed/30666100
http://dx.doi.org/10.2147/COPD.S184127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330967/
https://www.ncbi.nlm.nih.gov/pubmed/30666100
http://dx.doi.org/10.2147/COPD.S184127

Ejemplares similares